Deaths linked to Chikungunya virus infection were estimated at 0.1% in La Réunion. Chronic pain is of nociceptive but also neuropathic nature. Salicylates and other NSAIDs used in adults should ...

suggesting that this vaccine could be a viable option for preventing chikungunya virus infections[5]. The ongoing development of vaccines is crucial, especially as climate change and globalization ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect and spread the ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Guillain-Barre Syndrome (GBS) is a serious illness that often progresses rapidly, making the patient bedridden in a few days ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.